$NTNX
Nutanix, Inc. Stock $ntnx

$ntnx Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000161873220000144 Filed on December 03, 2020

Income Statement

Concept	2020 Q4	2019 Q4
Revenue	$312.8M	$314.8M
YoY Change	-0.64%	0.47%
Cost Of Revenue	$67.96M	$72.20M
YoY Change	-5.88%	-2.57%
Gross Profit	$244.8M	$242.6M
YoY Change	0.92%	1.42%
Gross Profit Margin	78.27%	77.06%
Selling, General & Admin	$291.1M	$324.7M
YoY Change	-10.36%	45.06%
% of Gross Profit	118.9%	133.86%
Research & Development	$135.8M	$138.2M
YoY Change	-1.74%	25.04%
% of Gross Profit	55.48%	56.98%
Depreciation & Amortization	$23.50M	$22.46M
YoY Change	4.62%	38.8%
% of Gross Profit	9.6%	9.26%
Operating Expenses	$426.9M	$462.9M
YoY Change	-7.78%	38.44%
Operating Profit	-$182.1M	-$220.3M
YoY Change	-17.37%	131.47%
Interest Expense	-$8.200M	-$7.600M
YoY Change	7.89%	7.04%
% of Operating Profit
Other Income/Expense, Net	-$78.73M	-$5.040M
YoY Change	1462.14%	86.46%
Pretax Income	-$260.8M	-$225.4M
YoY Change	15.72%	130.23%
Income Tax	$4.200M	$3.900M
% Of Pretax Income
Net Earnings	-$265.0M	-$229.3M
YoY Change	15.59%	143.25%
Net Earnings / Revenue	-84.75%	-72.85%
Basic Earnings Per Share
Diluted Earnings Per Share	-$1.305M	-$1.209M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.318B	$889.4M
YoY Change	48.2%	-7.83%
Cash & Equivalents	$504.5M	$233.8M
Short-Term Investments	$813.6M	$655.6M
Other Short-Term Assets	$15.54M	$13.90M
YoY Change	11.79%	-81.29%
Inventory
Prepaid Expenses
Receivables	$183.3M	$214.9M
Other Receivables	$8.500M	$5.600M
Total Short-Term Assets	$1.634B	$1.218B
YoY Change	34.17%	-4.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$133.2M	$140.5M
YoY Change	-5.21%	34.1%
Goodwill	$185.3M	$185.3M
YoY Change	0.0%	0.14%
Intangibles	$45.05M	$62.43M
YoY Change	-27.84%	-21.8%
Long-Term Investments
YoY Change
Other Assets	$24.04M	$17.26M
YoY Change	39.25%	-55.89%
Total Long-Term Assets	$681.8M	$648.5M
YoY Change	5.13%	30.72%
TOTAL ASSETS
Total Short-Term Assets	$1.634B	$1.218B
Total Long-Term Assets	$681.8M	$648.5M
Total Assets	$2.316B	$1.866B
YoY Change	24.08%	5.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.27M	$83.38M
YoY Change	-42.11%	20.02%
Accrued Expenses	$24.56M	$17.43M
YoY Change	40.89%	-38.94%
Deferred Revenue	$549.9M	$429.4M
YoY Change	28.06%	39.79%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$779.6M	$655.2M
YoY Change	18.98%	39.14%
LONG-TERM LIABILITIES
Long-Term Debt	$994.6M	$466.5M
YoY Change	113.2%	6.82%
Other Long-Term Liabilities	$33.33M	$16.83M
YoY Change	98.05%	-57.39%
Total Long-Term Liabilities	$33.33M	$16.83M
YoY Change	98.05%	-57.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$779.6M	$655.2M
Total Long-Term Liabilities	$33.33M	$16.83M
Total Liabilities	$2.873B	$1.803B
YoY Change	59.37%	34.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.858B	-$1.879B
YoY Change	52.14%	67.38%
Common Stock	$5.000K	$5.000K
YoY Change	0.0%	25.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$557.4M	$63.53M
YoY Change
Total Liabilities & Shareholders Equity	$2.316B	$1.866B
YoY Change	24.08%	5.26%

Cashflow Statement

Concept	2020 Q4	2019 Q4
OPERATING ACTIVITIES
Net Income	-$265.0M	-$229.3M
YoY Change	15.59%	143.25%
Depreciation, Depletion And Amortization	$23.50M	$22.46M
YoY Change	4.62%	38.8%
Cash From Operating Activities	-$4.073M	-$26.16M
YoY Change	-84.43%	-152.51%
INVESTING ACTIVITIES
Capital Expenditures	$12.25M	$18.20M
YoY Change	-32.69%	-38.98%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$416.4M	-$142.2M
YoY Change	192.92%	-416.05%
Cash From Investing Activities	-$428.7M	-$160.4M
YoY Change	167.31%	-1158.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$125.1M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	618.3M	$23.97M
YoY Change	2479.06%	-16.83%
NET CHANGE
Cash From Operating Activities	-4.073M	-$26.16M
Cash From Investing Activities	-428.7M	-$160.4M
Cash From Financing Activities	618.3M	$23.97M
Net Change In Cash	185.5M	-$162.6M
YoY Change	-214.13%	-273.31%
FREE CASH FLOW
Cash From Operating Activities	-$4.073M	-$26.16M
Capital Expenditures	$12.25M	$18.20M
Free Cash Flow	-$16.33M	-$44.37M
YoY Change	-63.2%	-321.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001618732
CY2020Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--07-31
CY2020Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2020Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q4	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020Q4	dei	Document Type DocumentType	10-Q
CY2020Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q4	dei	Document Period End Date DocumentPeriodEndDate	2020-10-31
CY2020Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q4	dei	Entity File Number EntityFileNumber	001-37883
CY2020Q4	dei	Entity Registrant Name EntityRegistrantName	NUTANIX, INC.
CY2020Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0989767
CY2020Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	1740 Technology Drive, Suite 150
CY2020Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose,
CY2020Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95110
CY2020Q4	dei	City Area Code CityAreaCode	(408)
CY2020Q4	dei	Local Phone Number LocalPhoneNumber	216-8360
CY2020Q4	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.000025 par value per share
CY2020Q4	dei	Trading Symbol TradingSymbol	NTNX
CY2020Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	401041000	USD
CY2020Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q4	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	318737000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	504482000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	813603000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	804000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	896000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	242516000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183270000	USD
CY2020Q3	ntnx	Deferredcommissionscurrentportion Deferredcommissionscurrentportion	68694000	USD
CY2020Q4	ntnx	Deferredcommissionscurrentportion Deferredcommissionscurrentportion	76047000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	63032000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56719000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	1094020000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1634121000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143172000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	133156000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127326000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	126542000	USD
CY2020Q3	ntnx	Deferredsalescommissionsnoncurrent Deferredsalescommissionsnoncurrent	146834000	USD
CY2020Q4	ntnx	Deferredsalescommissionsnoncurrent Deferredsalescommissionsnoncurrent	167711000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	49392000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45047000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	185260000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	185260000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22543000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24035000	USD
CY2020Q3	us-gaap	Assets Assets	1768547000	USD
CY2020Q4	us-gaap	Assets Assets	2315872000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	54029000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	48272000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	109109000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	115725000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25924000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24563000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	534572000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	549938000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36569000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41080000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	760203000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	779578000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	648869000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	656545000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	116794000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113491000	USD
CY2020Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	490222000	USD
CY2020Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	994637000	USD
CY2020Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	0	USD
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	295650000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27436000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33326000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	2043524000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2873227000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000025
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.000025
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	201949000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	201949000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	201346000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	201346000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2245180000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2299903000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2030000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	880000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2522192000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2858143000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-274977000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-557355000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1768547000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2315872000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	314768000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	312754000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	72201000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	67959000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	242567000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	244795000	USD
CY2019Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	291838000	USD
CY2020Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	257290000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	138206000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	135804000	USD
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32860000	USD
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33774000	USD
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	462904000	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	426868000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-220337000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-182073000	USD
CY2019Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5040000	USD
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-78732000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-225377000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-260805000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3923000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4243000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-229300000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-265048000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.21
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.31
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189671000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	203095000	shares
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-229300000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-266198000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	186893000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-265048000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	565000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1150000	USD
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-228735000	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2608000	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	21337000	USD
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81426000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	565000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-229300000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	63529000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-274977000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1631000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18070000	USD
CY2020Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	125079000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	89198000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1150000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-265048000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-557355000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-229300000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-265048000	USD
CY2019Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22462000	USD
CY2020Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23499000	USD
CY2019Q4	us-gaap	Share Based Compensation ShareBasedCompensation	81426000	USD
CY2020Q4	us-gaap	Share Based Compensation ShareBasedCompensation	89198000	USD
CY2019Q4	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
CY2020Q4	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	64740000	USD
CY2019Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7635000	USD
CY2020Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11708000	USD
CY2019Q4	ntnx	Increase Decreasein Operating Lease Cost Netof Accretion IncreaseDecreaseinOperatingLeaseCostNetofAccretion	6671000	USD
CY2020Q4	ntnx	Increase Decreasein Operating Lease Cost Netof Accretion IncreaseDecreaseinOperatingLeaseCostNetofAccretion	8347000	USD
CY2019Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	USD
CY2020Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2822000	USD
CY2019Q4	ntnx	Noncash Interest Expense NoncashInterestExpense	0	USD
CY2020Q4	ntnx	Noncash Interest Expense NoncashInterestExpense	1952000	USD
CY2019Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-103000	USD
CY2020Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1671000	USD
CY2019Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-30592000	USD
CY2020Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-60094000	USD
CY2019Q4	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	18313000	USD
CY2020Q4	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	28230000	USD
CY2019Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16150000	USD
CY2020Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6222000	USD
CY2019Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5208000	USD
CY2020Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4075000	USD
CY2019Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4786000	USD
CY2020Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10041000	USD
CY2019Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5772000	USD
CY2020Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1238000	USD
CY2019Q4	ntnx	Increase Decreasein Operating Leases Net IncreaseDecreaseinOperatingLeasesNet	-3469000	USD
CY2020Q4	ntnx	Increase Decreasein Operating Leases Net IncreaseDecreaseinOperatingLeasesNet	-7970000	USD
CY2019Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	65230000	USD
CY2020Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	22194000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26163000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4073000	USD
CY2019Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	171441000	USD
CY2020Q4	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	97578000	USD
CY2019Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	321474000	USD
CY2020Q4	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	513998000	USD
CY2019Q4	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	7870000	USD
CY2020Q4	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
CY2019Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18203000	USD
CY2020Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12252000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-160366000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-428672000	USD
CY2019Q4	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	23973000	USD
CY2020Q4	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	19600000	USD
CY2019Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	723757000	USD
CY2019Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	125079000	USD
CY2019Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23973000	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	618278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-162556000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	185533000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	399520000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321991000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	236964000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	507524000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	3144000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	3042000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233820000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	504482000	USD
CY2019Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7779000	USD
CY2020Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5050000	USD
CY2019Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12200000	USD
CY2020Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2948000	USD
CY2020Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; warranty liability; purchase commitment liabilities to our OEMs; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of operating right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the convertible senior notes due in 2026; and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the ongoing and rapidly evolving COVID-19 pandemic, we considered the impact of the estimated economic implications on our critical and significant accounting estimates, including assessment of collectibility of customer contracts, valuation of accounts receivable, provision for purchase commitments to our OEMs and impairment of long-lived assets, right-of-use assets, and deferred commissions.</span></div>
CY2020Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of RiskConcentration of revenue and accounts receivable—We sell our products primarily through our Partners and occasionally directly to end customers. For the three months ended October 31, 2019 and 2020, no end customer accounted for more than 10% of total revenue or accounts receivable.
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	314768000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	312754000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1183441000	USD
CY2020Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	215528000	USD
CY2020Q4	ntnx	Contractwith Customer Liability Additions ContractwithCustomerLiabilityAdditions	180044000	USD
CY2020Q4	ntnx	Contractwith Customer Asset Additions ContractwithCustomerAssetAdditions	67630000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-157002000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	-39400000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1206483000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	243758000	USD
CY2019Q4	ntnx	Deferred Revenue Revenue Recognized Amount Deferredin Prior Period DeferredRevenueRevenueRecognizedAmountDeferredinPriorPeriod	109000000.0	USD
CY2020Q4	ntnx	Deferred Revenue Revenue Recognized Amount Deferredin Prior Period DeferredRevenueRevenueRecognizedAmountDeferredinPriorPeriod	142700000	USD
CY2020Q4	ntnx	Deferred Revenue Contracted Revenue Not Recognized DeferredRevenueContractedRevenueNotRecognized	1247200000	USD
CY2020Q4	ntnx	Deferred Revenue Contracted Revenue Not Recognized Percent Expectedtobe Recognizedin Next Year DeferredRevenueContractedRevenueNotRecognizedPercentExpectedtobeRecognizedinNextYear	0.46
CY2020Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	230910000	USD
CY2020Q4	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	64740000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	295650000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	63032000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	631457000	USD
CY2020Q4	ntnx	Availableforsale Securities Debt Maturities Rolling Year Two Through Three Fair Value AvailableforsaleSecuritiesDebtMaturitiesRollingYearTwoThroughThreeFairValue	182146000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	813603000	USD
CY2020Q3	ntnx	Prepaid Operating Expense PrepaidOperatingExpense	31690000	USD
CY2020Q4	ntnx	Prepaid Operating Expense PrepaidOperatingExpense	32682000	USD
CY2020Q3	ntnx	Vat Receivables VATReceivables	8381000	USD
CY2020Q4	ntnx	Vat Receivables VATReceivables	8497000	USD
CY2020Q3	us-gaap	Tenant Improvements TenantImprovements	8557000	USD
CY2020Q4	us-gaap	Tenant Improvements TenantImprovements	0	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	14404000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	15540000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	398331000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56719000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	394397000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	251225000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	265175000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143172000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	133156000	USD
CY2020	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1200000	USD
CY2020Q4	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	900000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	92330000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	92330000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42938000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	47283000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	49392000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45047000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	13035000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16183000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10856000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3210000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	6666000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1763000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45047000	USD
CY2020Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	33503000	USD
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	39489000	USD
CY2020Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	24006000	USD
CY2020Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	26022000	USD
CY2020Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	10742000	USD
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	13466000	USD
CY2020Q3	ntnx	Accrued Benefits Espp Contributions AccruedBenefitsESPPContributions	16563000	USD
CY2020Q4	ntnx	Accrued Benefits Espp Contributions AccruedBenefitsESPPContributions	10810000	USD
CY2020Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8426000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	9343000	USD
CY2020Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	5568000	USD
CY2020Q3	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	10301000	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	9929000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	109109000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	115725000	USD
CY2020Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9703000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8333000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3006000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3528000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13215000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12702000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25924000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24563000	USD
CY2019Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	8700000	USD
CY2020Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	10400000	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3000000.0	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3000000.0	USD
CY2020	ntnx	Operating Lease Rightof Use Asset Impairment Loss OperatingLeaseRightofUseAssetImpairmentLoss	1800000	USD
CY2020	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1200000	USD
CY2020Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2800000	USD
CY2020Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2800000	USD
CY2020Q4	ntnx	Operating Lease Rightof Use Asset Impairment Loss OperatingLeaseRightofUseAssetImpairmentLoss	1900000	USD
CY2020Q4	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	900000	USD
CY2020Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	9976000	USD
CY2019Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12969000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	36153000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	47715000	USD
CY2020Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9918000	USD
CY2020Q4	ntnx	Operating Lease Rightof Use Asset Gross OperatingLeaseRightofUseAssetGross	166922000	USD
CY2020Q4	ntnx	Operating Lease Rightof Use Asset Accumulated Impairment OperatingLeaseRightofUseAssetAccumulatedImpairment	2382000	USD
CY2020Q4	ntnx	Operating Lease Rightof Use Asset Accumulated Amortization OperatingLeaseRightofUseAssetAccumulatedAmortization	37998000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	126542000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41080000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113491000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154571000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2019Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	8750000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	46281000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	31828000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6174000	USD
CY2020Q4	ntnx	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3798000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	171949000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17378000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	154571000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	41080000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113491000	USD
CY2020Q4	ntnx	Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount	5500000	USD
CY2020Q4	ntnx	Common Stock Numberof Classesof Stock CommonStockNumberofClassesofStock	2	class
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.000025
CY2020Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5200000	shares
CY2020Q4	ntnx	Numberof Equity Incentive Plans NumberofEquityIncentivePlans	3	plan
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	22632000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3454000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	24.02
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	2819000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	31.23
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	806000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	34.00
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.50
CY2020Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	300000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.48
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7200000	shares
CY2020Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.08
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M24D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	139600000	USD
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81426000	USD
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	89198000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	656900000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3900000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4200000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-229300000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-265048000	USD
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	189671000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	203095000	shares
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.21
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.31
CY2019Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33034000	shares
CY2020Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32786000	shares
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	314768000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	312754000	USD

Files In Submission

Name	View Source	Status
0001618732-20-000144-index-headers.html	Edgar Link	pending
0001618732-20-000144-index.html	Edgar Link	pending
0001618732-20-000144.txt	Edgar Link	pending
0001618732-20-000144-xbrl.zip	Edgar Link	pending
ex103-10312020x10q.htm	Edgar Link	pending
ex104-10312020x10q.htm	Edgar Link	pending
ex105-10312020x10q.htm	Edgar Link	pending
ex106-10312020x10q.htm	Edgar Link	pending
ex311-10312020x10q.htm	Edgar Link	pending
ex312-10312020x10q.htm	Edgar Link	pending
ex321-10312020x10q.htm	Edgar Link	pending
ex322-10312020x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ntnx-20201031.htm	Edgar Link	pending
ntnx-20201031.xsd	Edgar Link	pending
ntnx-20201031_cal.xml	Edgar Link	unprocessable
ntnx-20201031_def.xml	Edgar Link	unprocessable
ntnx-20201031_htm.xml	Edgar Link	completed
ntnx-20201031_lab.xml	Edgar Link	unprocessable
ntnx-20201031_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTNX
Nutanix, Inc. Stock $ntnx

2020 Q4 Form 10-Q Financial Statement

#000161873220000144 Filed on December 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTNX Nutanix, Inc. Stock $ntnx

2020 Q4 Form 10-Q Financial Statement

#000161873220000144 Filed on December 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTNX
Nutanix, Inc. Stock $ntnx